JFS Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59
Closed -$2.49K 2016
2023
Q2
$2.49K Sell
59
-16
-21% -$647 ﹤0.01% 1305
2023
Q1
$2.67K Buy
75
+44
+142% +$1.6K ﹤0.01% 1251
2022
Q4
$1.14K Sell
31
-36
-54% -$1.42K ﹤0.01% 1566
2022
Q3
$3K Buy
67
+11
+20% +$710 ﹤0.01% 1265
2022
Q2
$4K Buy
56
+29
+107% +$2.12K ﹤0.01% 1132
2022
Q1
$2K Sell
27
-3
-10% -$254 ﹤0.01% 1543
2021
Q4
$3K Buy
+30
New +$2.88K ﹤0.01% 1010

Other funds holding SYNH

JFS Wealth Advisors's SYNH Position: Q3 2023 in Review

JFS Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 59 shares — an estimated $2.49K sold.

JFS Wealth Advisors first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $4K in Q2 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • JFS Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • JFS Wealth Advisors sold 59 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.49K.
  • JFS Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • JFS Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $4K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on JFS Wealth Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.